RJ
Indaptus Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| INDP-101 | Advanced Solid Tumors | Phase 1 |
Leadership Team at Indaptus Therapeutics
JM
Jeffrey Meckler
Chief Executive Officer and Director
MJ
Michael J. Newman
Founder, President, and Chief Scientific Officer